BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 3223119)

  • 1. [The therapeutic value of second-look laparotomy in advanced ovarian carcinoma].
    Schneider J; Martin M; Erasun F; Matia JC; Rodriguez-Escudero FJ
    Zentralbl Gynakol; 1988; 110(22):1443-8. PubMed ID: 3223119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The indications for second-look laparotomy in ovarian cancer patients].
    Gulo EI; Vinokurov VL; Bokhman IaV
    Vopr Onkol; 1992; 38(5):616-23. PubMed ID: 1300762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
    Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR
    Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The controversial 'second-look' laparotomy.
    Bokhman YaV ; Vinokurov VL; Gulo EI
    Acta Obstet Gynecol Scand Suppl; 1992; 155():79-83. PubMed ID: 1502895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results.
    Bertucci F; Viens P; Delpero JR; Bardou VJ; Faucher C; Houvenaeghel G; Maraninchi D
    Bone Marrow Transplant; 2000 Jul; 26(1):61-7. PubMed ID: 10918406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second-look laparotomy in the management of epithelial ovarian carcinoma: an evaluation of fifty cases.
    Luesley DM; Chan KK; Fielding JW; Hurlow R; Blackledge GR; Jordon JA
    Obstet Gynecol; 1984 Sep; 64(3):421-6. PubMed ID: 6462573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical remission criteria for epithelial carcinoma of the ovary.
    Morikawa Y; Kawai M; Kano T; Kikkawa F; Oguchi H; Nakashima N; Ishizuka T; Furuhashi Y; Hattori SE; Kuzuya K
    Gynecol Oncol; 1993 Mar; 48(3):342-8. PubMed ID: 7681806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Second-look laparotomy in epithelial ovarian cancer: an evaluation of 23 cases].
    Liu LY
    Zhonghua Fu Chan Ke Za Zhi; 1990 Mar; 25(2):77-9, 123. PubMed ID: 2364794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value of cytoreductive second-look surgery in advanced epithelial ovarian carcinoma].
    Sevelda P; Barrada M; Vavra N; Denison U; Schmidl S; Genger H; Salzer H
    Wien Klin Wochenschr; 1990 Aug; 102(15):441-3. PubMed ID: 2402929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The current therapeutic approaches to advanced ovarian cancer.
    Nishimura H; Hamaguchi K; Miyahara K; Tazaki T; Tateno N; Yakushiji M
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Dec; 42(12):1691-6. PubMed ID: 2277209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Second-look and third-look laparotomies in follow-up of ovarian cancer. A critical review of 6 years' experience].
    Schneider J; Erasun F; Hervas JL; Miñambres JL
    Zentralbl Gynakol; 1987; 109(4):235-42. PubMed ID: 3591059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic, clinical and histological factors related to the survival of patients with advanced ovarian carcinoma.
    Kauppila A; Kivinen S; Mäkilä UM; Järvinen PA
    Ann Chir Gynaecol; 1981; 70(3):91-5. PubMed ID: 7325582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-look laparotomy in stage III epithelial ovarian cancer: clinical variables associated with disease status.
    Berek JS; Hacker NF; Lagasse LD; Poth T; Resnick B; Nieberg RK
    Obstet Gynecol; 1984 Aug; 64(2):207-12. PubMed ID: 6539884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Place of second-look laparotomy after 18 courses of chemotherapy in epithelial ovarian cancer.
    Ngan HY; Wong LC; Ma HK
    Aust N Z J Obstet Gynaecol; 1989 Feb; 29(1):52-4. PubMed ID: 2562603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of müllerian inclusions found at second-look laparotomy in patients with epithelial ovarian neoplasms.
    Copeland LJ; Silva EG; Gershenson DM; Sneige N; Atkinson EN; Wharton JT
    Obstet Gynecol; 1988 May; 71(5):763-70. PubMed ID: 2833713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-look laparotomy in ovarian cancer.
    Creasman WT
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S122-7. PubMed ID: 7835795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response.
    Vaccarello L; Rubin SC; Vlamis V; Wong G; Jones WB; Lewis JL; Hoskins WJ
    Gynecol Oncol; 1995 Apr; 57(1):61-5. PubMed ID: 7705701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management of ovarian carcinoma--a review of 420 cases.
    Barr W; Cowell AC; Chatfield WR
    Scott Med J; 1970 Jul; 15(7):250-6. PubMed ID: 5427786
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of secondary cytoreductive surgery in epithelial ovarian malignancies.
    Williams L
    Oncology (Williston Park); 1992 Aug; 6(8):25-32; discussion 37-9. PubMed ID: 1386995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.